CRISPR Gene Editing 2026: The Clinical Turning Point from Ex Vivo Casgevy to Direct In Vivo Delivery
In December 2023, Casgevy (exa-cel) received FDA and UK MHRA approval, becoming the world first approved CRISPR gene-editing therapy. It proved CRISPR...